Search

everythinglearnresearchcommunity

for

Search:↓

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Minoxidil 0.25 mg with spironolactone 25 mg reduces hair loss and improves hair density in women.

Lifestyle changes, medications, and fertility treatments can improve PCOS symptoms and prevent complications.

Menopausal acne is mainly caused by hormonal changes and can be managed with topical treatments, lifestyle changes, and sometimes medication.

Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.

Genetic testing for EGFR mutations is crucial in similar cases.

Idiopathic hirsutism may be linked to increased skin enzyme activity, and new treatments like laser and eflornithine cream show promise.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Hirsutism treatment should focus more on patient needs and quality of life.

Certain skin diseases are linked to Agent Orange and similar chemicals; veterans should be screened and informed about uncertain risks, and current data doesn't link spironolactone with breast cancer.

Hyperandrogenism, often causing excessive hair growth and acne, can be treated with methods like weight reduction, hair removal, various medications, and in the case of acne, topical treatments.

Stopping the drug usually helps, but tamoxifen or surgery may be needed if symptoms persist.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Some treatments like minoxidil, finasteride, and dutasteride are effective for hair loss, but there's no agreed best treatment.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

Most women with hirsutism have normal hormone levels and can be treated with cosmetic methods; obesity and PCOS are common causes, and treatments depend on the underlying issue.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Treating hair loss in PCOS involves a combination of lifestyle changes, medication, and possibly hair care strategies.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

Spironolactone is a safe and effective hair loss treatment, especially with minoxidil.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.